Published in Mol Cell Biol on August 01, 2000
Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor. Genes Dev (2004) 3.91
Apoptosis triggered by Myc-induced suppression of Bcl-X(L) or Bcl-2 is bypassed during lymphomagenesis. Mol Cell Biol (2001) 2.15
Myc potentiates apoptosis by stimulating Bax activity at the mitochondria. Mol Cell Biol (2001) 1.61
The Kaposi's sarcoma-associated herpesvirus LANA protein stabilizes and activates c-Myc. J Virol (2007) 1.36
The matrix protein CCN1 (CYR61) induces apoptosis in fibroblasts. J Cell Biol (2005) 1.26
Myc and Mad bHLHZ domains possess identical DNA-binding specificities but only partially overlapping functions in vivo. Proc Natl Acad Sci U S A (2002) 1.18
A conserved Myc protein domain, MBIV, regulates DNA binding, apoptosis, transformation, and G2 arrest. Mol Cell Biol (2006) 1.17
Involvement of p38 in apoptosis-associated membrane blebbing and nuclear condensation. Mol Biol Cell (2001) 1.16
Human c-Myc isoforms differentially regulate cell growth and apoptosis in Drosophila melanogaster. Mol Cell Biol (2005) 1.03
Targeting wild-type and mutant p53 with small molecule CP-31398 blocks the growth of rhabdomyosarcoma by inducing reactive oxygen species-dependent apoptosis. Cancer Res (2010) 0.98
Nuclear PI3K signaling in cell growth and tumorigenesis. Front Cell Dev Biol (2015) 0.96
Immortalization and transformation of human mammary epithelial cells by a tumor-derived Myc mutant. Breast Cancer Res Treat (2008) 0.94
Myc interacts with Max and Miz1 to repress C/EBPdelta promoter activity and gene expression. Mol Cancer (2010) 0.93
Cdk5-mediated phosphorylation of c-Myc on Ser-62 is essential in transcriptional activation of cyclin B1 by cyclin G1. J Biol Chem (2008) 0.92
Cytoplasmic death signal triggered by SRC-mediated phosphorylation of the adenovirus E4orf4 protein. Mol Cell Biol (2002) 0.91
Expression of MTLC gene in gastric carcinoma. World J Gastroenterol (2003) 0.87
A common functional consequence of tumor-derived mutations within c-MYC. Oncogene (2014) 0.86
Regulation of c-Myc expression by the histone demethylase JMJD1A is essential for prostate cancer cell growth and survival. Oncogene (2015) 0.82
Wnt pathway activation and ABCB1 expression account for attenuation of proteasome inhibitor-mediated apoptosis in multidrug-resistant cancer cells. Cancer Biol Ther (2015) 0.82
New model systems provide insights into Myc-induced transformation. Oncogene (2011) 0.80
Inducible transgenics. New lessons on events governing the induction and commitment in mammary tumorigenesis. Breast Cancer Res (2001) 0.79
ETV1 positively regulates transcription of tumor suppressor ARF. Cancer Biol Ther (2013) 0.77
Stimulation of Myc transactivation by the TATA binding protein in promoter-reporter assays. BMC Biochem (2005) 0.76
MYC-induced apoptosis in mammary epithelial cells is associated with repression of lineage-specific gene signatures. Cell Cycle (2016) 0.75
Induction of apoptosis in fibroblasts by c-myc protein. Cell (1992) 16.95
Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science (1991) 12.00
Inhibition of death receptor signals by cellular FLIP. Nature (1997) 9.58
Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev (1998) 9.03
c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol (1999) 8.17
A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res (1995) 7.95
Association of Myn, the murine homolog of max, with c-Myc stimulates methylation-sensitive DNA binding and ras cotransformation. Cell (1991) 5.76
Definition of regions in human c-myc that are involved in transformation and nuclear localization. Mol Cell Biol (1987) 5.67
The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev (1997) 5.58
Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature (1992) 5.50
c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. Proc Natl Acad Sci U S A (1997) 5.43
Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature (1997) 5.43
Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene (1991) 5.32
Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature (1992) 4.75
Chimaeras of myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells. Nature (1989) 4.65
Proteins of the Myc network: essential regulators of cell growth and differentiation. Adv Cancer Res (1996) 4.48
Mediation of c-Myc-induced apoptosis by p53. Science (1994) 4.45
Myc and Max proteins possess distinct transcriptional activities. Nature (1992) 4.16
Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1. Genes Dev (1994) 3.70
Destruction of Myc by ubiquitin-mediated proteolysis: cancer-associated and transforming mutations stabilize Myc. EMBO J (1999) 3.50
Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max. Nature (1992) 3.43
The Myc oncoprotein: a critical evaluation of transactivation and target gene regulation. Oncogene (1999) 3.17
Myc and Max associate in vivo. Genes Dev (1992) 3.16
c-Myc represses transcription in vivo by a novel mechanism dependent on the initiator element and Myc box II. EMBO J (1994) 3.01
Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition. Science (1999) 2.96
Akt/Protein kinase B inhibits cell death by preventing the release of cytochrome c from mitochondria. Mol Cell Biol (1999) 2.93
Isolation and characterization of c-myc, a cellular homolog of the oncogene (v-myc) of avian myelocytomatosis virus strain 29. J Virol (1982) 2.89
The c-Myc protein induces cell cycle progression and apoptosis through dimerization with Max. EMBO J (1993) 2.57
Requirement for the CD95 receptor-ligand pathway in c-Myc-induced apoptosis. Science (1997) 2.52
Point mutations in the c-Myc transactivation domain are common in Burkitt's lymphoma and mouse plasmacytomas. Nat Genet (1993) 2.47
c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release. Genes Dev (1999) 2.31
Mechanisms of apoptosis by c-Myc. Oncogene (1999) 2.26
Neoplastic transformation by the human gene N-myc. Mol Cell Biol (1987) 2.17
Site-specific modulation of c-Myc cotransformation by residues phosphorylated in vivo. Oncogene (1994) 2.05
Phosphorylation sites mapping in the N-terminal domain of c-myc modulate its transforming potential. Oncogene (1993) 1.91
Myc represses the growth arrest gene gadd45. Oncogene (1997) 1.86
Mechanisms of apoptosis avoidance in cancer. Curr Opin Oncol (1999) 1.81
Myc-mediated apoptosis is blocked by ectopic expression of Bcl-2. Mol Cell Biol (1993) 1.79
Sequence-specific transcriptional activation by Myc and repression by Max. Mol Cell Biol (1993) 1.77
Transactivation-defective c-MycS retains the ability to regulate proliferation and apoptosis. Genes Dev (1998) 1.74
Opposite regulation of gene transcription and cell proliferation by c-Myc and Max. Proc Natl Acad Sci U S A (1993) 1.70
Induction of ARF tumor suppressor gene expression and cell cycle arrest by transcription factor DMP1. Proc Natl Acad Sci U S A (1999) 1.65
c-Myc induces the expression and activity of ornithine decarboxylase. Cell Growth Differ (1993) 1.60
Induction of DNA synthesis and apoptosis are separable functions of E2F-1. Genes Dev (1997) 1.59
A link between increased transforming activity of lymphoma-derived MYC mutant alleles, their defective regulation by p107, and altered phosphorylation of the c-Myc transactivation domain. Mol Cell Biol (1995) 1.59
Ornithine decarboxylase is a mediator of c-Myc-induced apoptosis. Mol Cell Biol (1994) 1.55
Overexpression of c-Myc inhibits p21WAF1/CIP1 expression and induces S-phase entry in 12-O-tetradecanoylphorbol-13-acetate (TPA)-sensitive human cancer cells. Cell Growth Differ (1999) 1.47
Myc-mediated transformation: the repression connection. Oncogene (1999) 1.41
Clustered mutations in the second exon of the MYC gene in sporadic Burkitt's lymphoma. Oncogene (1993) 1.39
Regulation of c-Myc through phosphorylation at Ser-62 and Ser-71 by c-Jun N-terminal kinase. J Biol Chem (1999) 1.27
p53 modulation of anchorage independent growth and experimental metastasis. Oncogene (1996) 1.23
Ongoing mutations in the N-terminal domain of c-Myc affect transactivation in Burkitt's lymphoma cell lines. Oncogene (1994) 1.22
Myc represses transcription of the growth arrest gene gas1. Proc Natl Acad Sci U S A (1997) 1.13
A link between c-Myc-mediated transcriptional repression and neoplastic transformation. J Clin Invest (1996) 1.06
c-Myc induces apoptosis and cell cycle progression by separable, yet overlapping, pathways. Oncogene (1996) 1.05
Transformation of murine myelomonocytic cells by myc: point mutations in v-myc contribute synergistically to transforming potential. Oncogene (1989) 0.97
Myc inhibits CCAAT/enhancer-binding protein alpha-gene expression in HIB-1B hibernoma cells through interactions with the core promoter region. Eur J Biochem (1995) 0.92
Dissection of c-myc domains involved in S phase induction of NIH3T3 fibroblasts. Oncogene (1994) 0.85
Different regulation of c-Myc- and E2F-1-induced apoptosis during the ongoing cell cycle. Oncogene (1999) 0.76
4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt(PKB) signaling pathway. Genes Dev (1998) 6.89
Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. Genes Dev (2001) 6.15
The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev (1997) 5.58
Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. Genes Dev (2001) 5.12
The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB. Exp Cell Res (1999) 4.66
Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1. Genes Dev (1994) 3.70
Attenuation in the control of SV40 gene expression. Cell (1982) 3.32
Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt. Oncogene (2006) 3.17
Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3. Proc Natl Acad Sci U S A (2001) 3.02
Akt/Protein kinase B inhibits cell death by preventing the release of cytochrome c from mitochondria. Mol Cell Biol (1999) 2.93
A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents. Cancer Res (1999) 2.67
The taxanes: an update. Lancet (2000) 2.55
Neoplastic transformation by the human gene N-myc. Mol Cell Biol (1987) 2.17
Progression of LNCaP prostate tumor cells during androgen deprivation: hormone-independent growth, repression of proliferation by androgen, and role for p27Kip1 in androgen-induced cell cycle arrest. Mol Endocrinol (1998) 2.06
Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children's Cancer Group studies. J Clin Oncol (1996) 1.94
Global disease burden of conditions requiring emergency surgery. Br J Surg (2013) 1.92
Central venous catheters-time for a change?. If you put them in properly you don't need to change them routinely. BMJ (1998) 1.82
Myc-mediated apoptosis is blocked by ectopic expression of Bcl-2. Mol Cell Biol (1993) 1.79
Perioperative management of a case of severe peripartum cardiomyopathy. Anaesth Intensive Care (1992) 1.78
Sequence-specific transcriptional activation by Myc and repression by Max. Mol Cell Biol (1993) 1.77
c-Myc induces the expression and activity of ornithine decarboxylase. Cell Growth Differ (1993) 1.60
Increased androgen receptor activity and altered c-myc expression in prostate cancer cells after long-term androgen deprivation. Cancer Res (1994) 1.52
The effect of cyclosporine on the use of hospital resources for kidney transplantation. N Engl J Med (1989) 1.49
Does neostigmine increase gastric emptying in the critically ill?--results of a pilot study. Crit Care Resusc (2003) 1.47
Changes in body mass index and prevalence of overweight in survivors of childhood acute lymphoblastic leukemia: role of cranial irradiation. Med Pediatr Oncol (2000) 1.45
The North Dublin randomized controlled trial of structured diabetes shared care. Fam Pract (2004) 1.44
Attenuation of late simian virus 40 mRNA synthesis is enhanced by the agnoprotein and is temporally regulated in isolated nuclear systems. Mol Cell Biol (1985) 1.43
Akt, a target of phosphatidylinositol 3-kinase, inhibits apoptosis in a differentiating neuronal cell line. Mol Cell Biol (1998) 1.41
The role of RNA molecules in transduction of the proto-oncogene c-fps. Cell (1986) 1.39
Transcription enhancer factor 1 interacts with a basic helix-loop-helix zipper protein, Max, for positive regulation of cardiac alpha-myosin heavy-chain gene expression. Mol Cell Biol (1997) 1.37
Isolation of Chlamydia trachomatis from the lower respiratory tract of adults. Lancet (1980) 1.37
Attenuation in SV40 as a mechanism of transcription-termination by RNA polymerase B. Nucleic Acids Res (1984) 1.35
Repeated CT elements bound by zinc finger proteins control the absolute and relative activities of the two principal human c-myc promoters. Mol Cell Biol (1993) 1.29
Auditory brainstem implant: II. Postsurgical issues and performance. Otolaryngol Head Neck Surg (1993) 1.27
Response to antituberculous chemotherapy after splenectomy. J Intern Med (1993) 1.25
Mutant presenilin-1 induces apoptosis and downregulates Akt/PKB. J Neurosci (1999) 1.24
Attenuation may regulate gene expression in animal viruses and cells. CRC Crit Rev Biochem (1985) 1.21
Site of premature termination of late transcription of simian virus 40 DNA: enhancement by 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole. Proc Natl Acad Sci U S A (1982) 1.20
Final height after treatment for childhood acute lymphoblastic leukemia: comparison of no cranial irradiation with 1800 and 2400 centigrays of cranial irradiation. J Pediatr (1993) 1.19
Activation of NF-kappa B by bradykinin through a Galpha(q)- and Gbeta gamma-dependent pathway that involves phosphoinositide 3-kinase and Akt. J Biol Chem (2000) 1.17
p21 Disrupts the interaction between cdk2 and the E2F-p130 complex. Mol Cell Biol (1996) 1.16
The role of PAK-1 in activation of MAP kinase cascade and oncogenic transformation by Akt. Oncogene (2009) 1.14
A qualitative investigation of the views and health beliefs of patients with Type 2 diabetes following the introduction of a diabetes shared care service. Diabet Med (2003) 1.11
Transcription termination in animal viruses and cells. Gene (1988) 1.06
A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function. Oncogene (2001) 1.05
The novel cyclin-dependent kinase inhibitor dinaciclib (SCH727965) promotes apoptosis and abrogates microenvironmental cytokine protection in chronic lymphocytic leukemia cells. Leukemia (2012) 1.05
Organ-specific modulation of gene expression in transgenic plants using antisense RNA. Plant Mol Biol (1990) 1.05
A multicenter phase II study of pazopanib in patients with advanced gastrointestinal stromal tumors (GIST) following failure of at least imatinib and sunitinib. Ann Oncol (2014) 1.03
In vitro premature termination in SV40 late transcription. EMBO J (1983) 1.02
Chronic pelvic pain syndrome. BMJ (1999) 1.02
A kinetic analysis of the nucleotide-induced allosteric transitions of GroEL. J Mol Biol (1999) 1.02
Deletion of a nonconserved region of Bcl-2 confers a novel gain of function: suppression of apoptosis with concomitant cell proliferation. Cancer Res (1996) 0.99
Tubuloglomerular feedback dynamics and renal blood flow autoregulation in rats. Am J Physiol (1991) 0.99
Expression, regulation, and chromosomal localization of the Max gene. Proc Natl Acad Sci U S A (1992) 0.98
Role of the intramolecular phase in high-harmonic generation. Phys Rev Lett (2002) 0.96
The effect Akt2 deletion on tumor development in Pten(+/-) mice. Oncogene (2011) 0.96
Control of late simian virus 40 transcription by the attenuation mechanism and transcriptionally active ternary complexes are associated with the nuclear matrix. J Mol Biol (1984) 0.96
Pharmacokinetics, immune response, and biodistribution of iodine-131-labeled chimeric mouse/human IgG1,k 17-1A monoclonal antibody. J Nucl Med (1991) 0.96
Detection of apical Na(+)/H(+) exchanger activity inhibition in proximal tubules induced by acute hypertension. Am J Physiol Regul Integr Comp Physiol (2000) 0.95
Attenuation and modulation of mRNA secondary structure in a feedback control system regulating SV40 gene expression. Mol Biol Rep (1983) 0.94
Lattice Boltzmann simulations of contact line motion. I. Liquid-gas systems. Phys Rev E Stat Nonlin Soft Matter Phys (2004) 0.92
Escherichia coli pyruvate oxidase: interaction of a peripheral membrane protein with lipids. Biophys J (1982) 0.92
A phase I clinical and pharmacokinetic study of the multi-drug resistance protein-1 (MRP-1) inhibitor sulindac, in combination with epirubicin in patients with advanced cancer. Cancer Chemother Pharmacol (2006) 0.90
Retracted Blockage of the early events of mitogenic signaling by interferon-gamma in macrophages in response to colony-stimulating factor-1. Blood (1995) 0.88
Folic acid supplements to prevent neural tube defects: trends in East of Ireland 1996-2002. Ir Med J (2004) 0.88
Effects of interferon beta ser and transforming growth factor beta on prostatic cell lines. J Urol (1991) 0.87
Life-threatening neuropathy and hepatotoxicity in infants during induction therapy for acute lymphoblastic leukemia. J Pediatr (1981) 0.87
Dynamics of renal blood flow autoregulation in rats. Kidney Int Suppl (1991) 0.86
Apoptosis induced by differentiation or serum deprivation in an immortalized central nervous system neuronal cell line. J Neurochem (1996) 0.86
The immune system and the histiocytosis syndromes. Am J Pediatr Hematol Oncol (1981) 0.86
The characterization of Listeria spp. isolated from food products and the food-processing environment. Lett Appl Microbiol (2010) 0.85
Patterns of blood pressure variability in normotensive and hypertensive rats. Am J Physiol (1995) 0.85
Recurrent femoral hernia and associated ovarian pathology. BMJ Case Rep (2012) 0.85
A case of primary mesenteric fibromatosis. Aust N Z J Surg (1992) 0.85
Differential expression of suppressors of cytokine signalling genes in response to nutrition and growth hormone in the septic rat. J Endocrinol (2001) 0.85
Symmetric free-energy-based multicomponent lattice Boltzmann method. Phys Rev E Stat Nonlin Soft Matter Phys (2007) 0.85
Neurochemical alterations in Rett syndrome. Brain Res Dev Brain Res (1993) 0.84
Cytogenetic and molecular heterogeneity of 7q36/12p13 rearrangements in childhood AML. Leukemia (2002) 0.84
Prevalence of sexually transmitted diseases and human immunodeficiency virus among women attending prenatal services in Apia, Samoa. Int J STD AIDS (2004) 0.84
Structural analysis of the mouse prosaposin (SGP-1) gene reveals the presence of an exon that is alternatively spliced in transcribed mRNAs. Mol Reprod Dev (1997) 0.83
Effects of dietary sodium substitution with potassium and magnesium in hypertensive type II diabetics: a randomised blind controlled parallel study. J Hum Hypertens (1996) 0.83
Failure of the Ambicor inflatable penile prosthesis to deflate. Int J Impot Res (2005) 0.82
SV40 deletion mutant (d1861) with agnoprotein shortened by four amino acids. Virology (1984) 0.82
Bone marrow transplantation for children with acute leukemia and Down syndrome. Pediatrics (1986) 0.82
Asymptomatic primary fallopian tube cancer: an unusual cause of axillary lymphadenopathy. Case Rep Obstet Gynecol (2011) 0.82
Typhoid ileal perforations: a retrospective study. Ann R Coll Surg Engl (1990) 0.82
Botulinum toxin urethral sphincter injection resolves urinary retention after pubovaginal sling operation. Int Urogynecol J Pelvic Floor Dysfunct (2002) 0.81
Common dental features and craniofacial development of three siblings with Ter Haar syndrome. Eur Arch Paediatr Dent (2013) 0.81
Efficient recovery and regeneration of integrated retroviruses. Nucleic Acids Res (1997) 0.81
Distribution of mouse sulfated glycoprotein-1 (prosaposin) in the testis and other tissues. J Androl (1998) 0.81
Tonsillectomy--cold dissection vs. hot dissection: a prospective study. Ir Med J (2006) 0.81